Cite
Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes
MLA
Pinak B. Shah, et al. “Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes.” JAMA Cardiology, vol. 5, no. 2, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9462f40fe823d9d4fbe477135fbe338c&authtype=sso&custid=ns315887.
APA
Pinak B. Shah, Siobhan McGurk, Julius I. Ejiofor, Patrick T. O’Gara, Ahmed A Kolkailah, Fernando Ramirez-Del Val, Marc P. Pelletier, Natalia Berry, Tsuyoshi Kaneko, Piotr Sobieszczyk, Spencer Kiehm, & Sameer A. Hirji. (2019). Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes. JAMA Cardiology, 5(2).
Chicago
Pinak B. Shah, Siobhan McGurk, Julius I. Ejiofor, Patrick T. O’Gara, Ahmed A Kolkailah, Fernando Ramirez-Del Val, Marc P. Pelletier, et al. 2019. “Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes.” JAMA Cardiology 5 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9462f40fe823d9d4fbe477135fbe338c&authtype=sso&custid=ns315887.